Kanakaveti, V.; Ramasamy, S.; Kanumuri, R.; Balasubramanian, V.; Saravanan, R.; Ezhil, I.; Pitani, R.; Venkatraman, G.; Rayala, S.K.; Gromiha, M.M.
Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer. Cancers 2022, 14, 5241.
https://doi.org/10.3390/cancers14215241
AMA Style
Kanakaveti V, Ramasamy S, Kanumuri R, Balasubramanian V, Saravanan R, Ezhil I, Pitani R, Venkatraman G, Rayala SK, Gromiha MM.
Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer. Cancers. 2022; 14(21):5241.
https://doi.org/10.3390/cancers14215241
Chicago/Turabian Style
Kanakaveti, Vishnupriya, Sakthivel Ramasamy, Rahul Kanumuri, Vaishnavi Balasubramanian, Roshni Saravanan, Inemai Ezhil, Ravishankar Pitani, Ganesh Venkatraman, Suresh Kumar Rayala, and M. Michael Gromiha.
2022. "Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer" Cancers 14, no. 21: 5241.
https://doi.org/10.3390/cancers14215241
APA Style
Kanakaveti, V., Ramasamy, S., Kanumuri, R., Balasubramanian, V., Saravanan, R., Ezhil, I., Pitani, R., Venkatraman, G., Rayala, S. K., & Gromiha, M. M.
(2022). Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer. Cancers, 14(21), 5241.
https://doi.org/10.3390/cancers14215241